Nano Labs Ltd (Nasdaq: NA) (“we,” the “Company” or “Nano Labs”), a
leading fabless integrated circuit design company and product
solution provider in China, today announced its unaudited financial
results as of December 31, 2023 and for the six months ended
December 31, 2023
Second Half of 2023 Financial
Highlights
- Net revenue was
RMB26.1 million (US$3.7 million) for the second half of 2023,
compared to RMB603.0 million in the same period of 2022.
- Gross loss was
RMB40.6 million (US$5.7 million) for the second half of 2023,
compared to a gross profit of RMB53.8 million in the same period of
2022.
- Loss from
operations was RMB124 million (US$17.6 million) for the second half
of 2023, compared to a loss from operations of RMB86.9 million in
the same period of 2022.
- Net loss was
RMB120.0 million (US$16.9 million) for the second half of 2023,
compared to a net loss of RMB80.3 million in the same period of
2022.
- Net loss per
share (both basic and diluted) was RMB1.91 (US$0.27) for the second
half of 2023, compared to a net loss per share (both basic and
diluted) of RMB1.47 in the same period of 2022.
Mr. Jianping Kong, Chairman and Chief Executive
Officer of the Company, commented, “In the second half of 2023, our
company benefited from supportive government policy and positive
market trends. The Hong Kong government's strong support for the
web3.0 industry and the historic approval of the first Bitcoin spot
ETF by the SEC in early 2024 have bolstered the industry, infusing
optimism and propelling progress. Our management team is actively
pursuing global market expansion opportunities. Through a series of
market expansion initiatives, we aim to continue exploring
potential market opportunities to increase our market share.
In terms of research and development, our Cuckoo
series iterative products are currently undergoing intensive
R&D efforts. Significant advancements were made in the latter
half of 2023, and we anticipate the launch of enhanced versions of
our products in 2024, which are expected to deliver substantially
improved performance. Additionally, our company is concurrently
upgrading our packaging technology and IP to enhance the efficiency
of chip production. We are also laying the groundwork for research
and development of AI computing, ZK computing, and other chips to
seize emerging market opportunities.
Our metaverse business line, iPollo Metaverse,
offers a photography studio service that includes 3D scanning and
3D printing services. This service has not only received high
praise from athletes at the Asian Games but has also provided
diverse digital application scenarios for various IPs. It assists
in the digitalization of various types of IPs, helping them enter
the metaverse track. Furthermore, the photography studio service
offers personalized customization services to users, allowing a
wide range of enthusiasts to experience the joy of DIY in the
metaverse.”
Mr. Bing Chen, Chief Financial Officer,
commented, “For the second half of 2023, our net revenue was
RMB26.1 million (US$3.7 million). In addition, the net loss was
RMB120.0 million (US$16.9 million) for the six months ended
December 31, 2023, compared to a net loss of RMB80.3 million in the
same period of 2022. While the company's performance in the second
half of 2023 may not have met expectations, we are encouraged by
the gradual recovery in the market. We firmly believe that with the
favorable policies and support, coupled with our continuous
dedication and efforts, we will continue to progress and provide
foundational services for the development of the web3.0
industry!”
Second Half of 2023 Financial
Results
Net Revenues
Net revenue was RMB26.1 million (US$3.7 million)
for the second half of 2023, compared to RMB603.0 million for the
same period of 2022. The decrease in net revenues was primarily due
to the drop of sales volume of iPollo V1 Series and B1 Series. The
revenues in 3D-printing products, our new products, was RMB787
thousand for the second half of 2023, compared to nil for the same
period of 2022.
Cost of Revenues
Cost of revenues was RMB66.6 million (US$9.4
million) for the second half of 2023, compared to RMB549.2 million
for the same period of 2022. The change was mainly due to the
decrease in sales volume and partially offset by an increase in
inventory write-down.
The cost of 3D-printing products was RMB629
thousand for the second half of 2023, compared to nil for the same
period of 2022.
Operating Expenses
Total operating expenses decreased by 40.4% to
RMB83.8 million (US$11.8 million) for the second half of 2023, from
RMB140.7 million for the same period of 2022.
- Selling and
marketing expenses decreased to RMB5.8 million (US$0.8 million) for
the second half of 2023, from RMB14.3 million for the same period
of 2022. The decrease in selling and marketing expenses was
primarily due to the decrease in advertising fee and marketing
promotion expenses.
- General and administrative expenses decreased by 38.4% to
RMB22.4 million (US$3.2 million) for the second half of 2023, from
RMB36.3 million for the same period of 2022. The decrease in
general and administrative expenses was primarily due to the
decrease in professional fees and employee salary expenses as the
number and salaries of general and administrative staff
decreased.
- Research and
development expenses decreased by 38.3% to RMB55.6 million (US$7.9
million) for the second half of 2023, from RMB90.2 million for the
same period of 2022. The decrease in research and development
expenses was primarily due to the decrease in equipment cost,
salary expenses and share-based compensation expenses. The Company
expects to continue its significant investment in research and
development to support its future development, product iteration,
and competitive strengths.
Loss from Operations
Loss from operations was RMB124.4 million
(US$17.6 million) for the second half of 2023, compared with loss
from operations of RMB86.9 million for the same period of 2022.
Finance Income
Finance income was RMB0.7 million (US$0.1
million) for the second half of 2023, compared with finance income
of RMB3.8 million for the same period of 2022.
Net Loss
Net loss was RMB120.0 million (US$16.9 million)
for the second half of 2023, compared with RMB80.3 million in the
same period of 2022.
Basic and Diluted Loss Per Ordinary
Share attributable to Nano Labs Ltd
Basic and diluted loss per share was RMB1.91
(US$0.27) for the second half of 2023, compared with basic and
diluted loss per share of RMB1.47 for the same period of 2022.
Cash and Cash Equivalents
As of December 31, 2023, the Company had cash
and cash equivalents of RMB48.2 million (US$6.8 million), compared
with RMB87.8 million as of December 31, 2022.
Exchange Rate
This press release contains translations of
certain Renminbi (RMB) amounts into U.S. dollars (US$) solely for
the convenience of the reader. Unless otherwise specified, all
translations of Renminbi amounts into U.S. dollar amounts in this
press release are made at RMB7.0827 to US$1.00, the central parity
rate on December 31, 2023 published by the People’s Bank of
China.
Non-GAAP Financial Measures
In evaluating our business, we consider and use
adjusted net income/(loss) as an additional non-GAAP measure to
review and assess our operating performance. The presentation of
the non-GAAP financial measure is not intended to be considered in
isolation or as a substitute for the financial information prepared
and presented in accordance with U.S. GAAP. We define adjusted net
income/(loss) as net income/(loss) excluding share-based
compensation expense.
We present the non-GAAP financial measure
because they are used by our management to evaluate our operating
performance and formulate business plans. Non-GAAP financial
measures enable our management to assess our operating results
without considering the impact of non-cash charges and
non-operating items. We also believe that the use of the non-GAAP
measure facilitates investors’ assessment of our operating
performance.
The non-GAAP financial measure is not defined
under U.S. GAAP and is not presented in accordance with U.S. GAAP.
The non-GAAP financial measure has limitations as analytical tools.
One of the key limitations of using the non-GAAP financial measure
is that they do not reflect all items of income and expense that
affect our operations. Share-based compensation expenses have
been and may continue to be incurred in our business and are not
reflected in the presentation of adjusted net income/(loss).
Further, the non-GAAP measure may differ from the non-GAAP
information used by other companies, including peer companies, and
therefore their comparability may be limited.
Conference Call
The Company will host an earnings conference call to discuss its
financial results at 8:30 am U.S. Eastern Time (8:30 pm Beijing
Time) on March 18, 2024.
For participants who wish to join the call, please access the
link provided below to complete the online registration
process.
Registration Link:
https://s1.c-conf.com/diamondpass/10037655-rw885f.html
Upon registration, participants will receive the
dial-in number and unique PIN, which can be used to join the
conference call. If participants register and forget their PIN or
lose their registration confirmation email, they may simply
re-register and receive a new PIN. All participants are encouraged
to dial in 15 minutes prior to the start time.
A live and archived webcast of the conference call will be
accessible on the Company's investor relations website at:
https://ir.nano.cn/.
A telephone replay of the call will be available until 25 March,
2024 via the following dial-in details:
Dial-in Numbers:
US/Canada: |
1855 883 1031 |
Hong Kong: |
800 930 639 |
China: |
400 1209 216 |
Replay PIN: |
10037655 |
About Nano Labs Ltd
Nano Labs Ltd is a leading fabless integrated
circuit (“IC”) design company and product solution provider in
China. Nano Labs is committed to the development of high throughput
computing (“HTC”) chips, high performance computing (“HPC”) chips,
distributed computing and storage solutions, smart network
interface cards (“NICs”) vision computing chips and distributed
rendering. Nano Labs has built a comprehensive flow processing unit
(“FPU”) architecture which offers solution that integrates the
features of both HTC and HPC. Nano Lab’s Cuckoo series are one of
the first near-memory HTC chips available in the market*. For more
information, please visit the Company’s website at: ir.nano.cn.
*According to an industry report prepared by
Frost & Sullivan.
Forward-Looking Statements
This report contains forward-looking statements
within the meaning of Section 21E of the Securities Exchange Act of
1934, as amended, and as defined in the U.S. Private Securities
Litigation Reform Act of 1995. These forward-looking statements
include, without limitation, the Company’s plan to appeal the
Staff’s determination, which can be identified by terminology such
as “may,” “will,” “expect,” “anticipate,” “aim,” “estimate,”
“intend,” “plan,” “believe,” “potential,” “continue,” “is/are
likely to” or other similar expressions. Such statements are based
upon management’s current expectations and current market and
operating conditions, and relate to events that involve known or
unknown risks, uncertainties and other factors, all of which are
difficult to predict and many of which are beyond the Company’s
control, which may cause the Company’s actual results, performance
or achievements to differ materially from those in the
forward-looking statements. Further information regarding these and
other risks, uncertainties or factors is included in the Company’s
filings with the Securities and Exchange Commission. The Company
does not undertake any obligation to update any forward-looking
statement as a result of new information, future events or
otherwise, except as required under law.
For investor and media inquiries, please
contact:
Nano Labs Ltd
Email: ir@nano.cn
Ascent Investor Relations LLC
Tina Xiao
Phone: +1-646-932-7242
Email: investors@ascent-ir.com
Consolidated Balance Sheets |
(Unaudited) |
|
|
|
|
|
|
|
As of December 31, |
|
As of December 31, |
|
2022 |
|
2023 |
|
RMB |
|
RMB |
|
US$ |
ASSETS |
|
|
|
|
|
Current
assets: |
|
|
|
|
|
Cash and cash equivalents |
87,811,272 |
|
|
48,164,664 |
|
|
6,800,325 |
|
Restricted cash |
48,112 |
|
|
417,990 |
|
|
59,016 |
|
Accounts receivable, net |
- |
|
|
1,739,065 |
|
|
245,537 |
|
Inventories, net |
102,201,746 |
|
|
12,874,986 |
|
|
1,817,808 |
|
Prepayments |
71,314,254 |
|
|
24,386,010 |
|
|
3,443,039 |
|
Other current assets |
27,275,215 |
|
|
37,908,092 |
|
|
5,352,209 |
|
Total current
assets |
288,650,599 |
|
|
125,490,807 |
|
|
17,717,934 |
|
Non-current
assets: |
|
|
|
|
|
Property, plant and equipment, net |
21,426,955 |
|
|
169,653,582 |
|
|
23,953,236 |
|
Intangible asset, net |
48,717,132 |
|
|
47,731,288 |
|
|
6,739,137 |
|
Operating lease right-of-use assets |
8,447,978 |
|
|
7,424,554 |
|
|
1,048,266 |
|
Total non-current
assets |
78,592,065 |
|
|
224,809,424 |
|
|
31,740,639 |
|
|
|
|
|
|
|
TOTAL
ASSETS |
367,242,664 |
|
|
350,300,231 |
|
|
49,458,573 |
|
|
|
|
|
|
|
LIABILITIES AND
SHAREHOLDERS' EQUITY (DEFICIT) |
|
|
|
|
|
Current
liabilities: |
|
|
|
|
|
Short-term debts |
- |
|
|
20,000,000 |
|
|
2,823,782 |
|
Current portion of long-term debts |
280,000 |
|
|
3,410,000 |
|
|
481,455 |
|
Accounts payable |
15,292,843 |
|
|
16,875,586 |
|
|
2,382,649 |
|
Advance from customers |
124,469,097 |
|
|
107,826,617 |
|
|
15,223,942 |
|
Operating lease liabilities, current |
4,199,361 |
|
|
3,479,752 |
|
|
491,303 |
|
Other current liabilities |
39,399,532 |
|
|
90,978,171 |
|
|
12,845,126 |
|
Total current
liabilities |
183,640,833 |
|
|
242,570,126 |
|
|
34,248,257 |
|
Non-current
liabilities: |
|
|
|
|
|
Long-term debts |
16,673,316 |
|
|
120,260,783 |
|
|
16,979,511 |
|
Operating lease liabilities, non-current |
2,514,115 |
|
|
3,730,672 |
|
|
526,730 |
|
Total non-current
liabilities |
19,187,431 |
|
|
123,991,455 |
|
|
17,506,241 |
|
Total
liabilities |
202,828,264 |
|
|
366,561,581 |
|
|
51,754,498 |
|
Shareholders' equity
(deficit): |
|
|
|
|
|
Class A ordinary shares ($0.0002 par value; 121,410,923 shares
authorized; 27,159,258 and 41,927,302 shares issued as of December
31, 2022 and 2023, respectively; 27,159,258 and 37,242,359 shares
outstanding as of December 31, 2022 and 2023, respectively)* |
35,425 |
|
|
50,106 |
|
|
7,074 |
|
Class B ordinary shares ($0.0002 par value; 28,589,078 shares
authorized; 28,589,078 shares issued and outstanding as of December
31, 2022 and December 31, 2023)* |
36,894 |
|
|
36,894 |
|
|
5,209 |
|
Additional paid-in capital |
354,803,564 |
|
|
428,310,028 |
|
|
60,472,706 |
|
Accumulated deficit |
(199,207,921 |
) |
|
(452,031,693 |
) |
|
(63,821,945 |
) |
Statutory reserves |
6,647,109 |
|
|
6,647,109 |
|
|
938,499 |
|
Accumulated other comprehensive income |
2,099,329 |
|
|
2,254,558 |
|
|
318,319 |
|
Total Nano Labs Ltd
shareholders' equity (deficit) |
164,414,400 |
|
|
(14,732,998 |
) |
|
(2,080,138 |
) |
Noncontrolling interests |
- |
|
|
(1,528,352 |
) |
|
(215,787 |
) |
Total shareholders'
equity (deficit) |
164,414,400 |
|
|
(16,261,350 |
) |
|
(2,295,925 |
) |
|
|
|
|
|
|
TOTAL LIABILITIES AND
SHAREHOLDERS' EQUITY (DEFICIT) |
367,242,664 |
|
|
350,300,231 |
|
|
49,458,573 |
|
*Giving effect of the 2-for-1 reverse stock split effective on
January 31, 2024.
Consolidated Statements of Operations and Comprehensive
Income (Loss) |
(Unaudited) |
|
|
|
|
|
|
|
For the six months ended December 31, |
|
2022 |
|
2023 |
|
RMB |
|
RMB |
|
US$ |
Net revenues |
603,030,131 |
|
|
26,066,660 |
|
|
3,680,328 |
|
Cost of
revenues |
549,236,760 |
|
|
66,617,485 |
|
|
9,405,662 |
|
Gross profit
(loss) |
53,793,371 |
|
|
(40,550,825 |
) |
|
(5,725,334 |
) |
|
|
|
|
|
|
Operating
expenses: |
|
|
|
|
|
Selling and marketing expenses |
14,266,412 |
|
|
5,830,986 |
|
|
823,272 |
|
General and administrative expenses |
36,311,852 |
|
|
22,360,766 |
|
|
3,157,096 |
|
Research and development expenses |
90,159,028 |
|
|
55,648,133 |
|
|
7,856,910 |
|
Total operating
expenses |
140,737,292 |
|
|
83,839,885 |
|
|
11,837,278 |
|
|
|
|
|
|
|
Loss from
operations |
(86,943,921 |
) |
|
(124,390,710 |
) |
|
(17,562,612 |
) |
|
|
|
|
|
|
Other expenses
(income): |
|
|
|
|
|
Finance income |
(3,771,346 |
) |
|
(680,536 |
) |
|
(96,084 |
) |
Interest income |
(144,938 |
) |
|
(153,112 |
) |
|
(21,618 |
) |
Other income |
(2,752,999 |
) |
|
(3,507,095 |
) |
|
(495,164 |
) |
Total other
income |
(6,669,283 |
) |
|
(4,340,743 |
) |
|
(612,866 |
) |
|
|
|
|
|
|
Loss before income tax
provision |
(80,274,638 |
) |
|
(120,049,967 |
) |
|
(16,949,746 |
) |
Income tax provision |
- |
|
|
(17,394 |
) |
|
(2,456 |
) |
Net loss |
(80,274,638 |
) |
|
(120,032,573 |
) |
|
(16,947,290 |
) |
Less: net loss
attributable to noncontrolling interests |
- |
|
|
(1,528,282 |
) |
|
(215,777 |
) |
Net loss attributable
to Nano Labs Ltd |
(80,274,638 |
) |
|
(118,504,291 |
) |
|
(16,731,513 |
) |
|
|
|
|
|
|
Comprehensive income
(loss): |
|
|
|
|
|
Net loss |
(80,274,638 |
) |
|
(120,032,573 |
) |
|
(16,947,290 |
) |
Other comprehensive income
(loss): |
|
|
|
|
|
Foreign currency translation adjustment |
3,229,764 |
|
|
(1,616,096 |
) |
|
(228,175 |
) |
Comprehensive
Loss |
(77,044,874 |
) |
|
(121,648,669 |
) |
|
(17,175,465 |
) |
Comprehensive loss
attributable to noncontrolling interests |
- |
|
|
(1,528,352 |
) |
|
(215,787 |
) |
Comprehensive loss
attributable to Nano Labs Ltd |
(77,044,874 |
) |
|
(120,120,317 |
) |
|
(16,959,678 |
) |
|
|
|
|
|
|
Net loss per ordinary
share attributable to Nano Labs Ltd |
|
|
|
|
|
Basic* |
(1.47 |
) |
|
(1.91 |
) |
|
(0.27 |
) |
Diluted* |
(1.47 |
) |
|
(1.91 |
) |
|
(0.27 |
) |
|
|
|
|
|
|
Weighted average
number of shares used in per share calculation: |
|
|
|
|
|
Basic* |
54,571,995 |
|
|
61,970,664 |
|
|
61,970,664 |
|
Diluted* |
54,571,995 |
|
|
61,970,664 |
|
|
61,970,664 |
|
*Giving effect of the 2-for-1 reverse stock split effective on
January 31, 2024.
Non-GAAP Reconciliation |
(Unaudited) |
|
For the Six Months Ended December 31, |
|
2022 |
|
2023 |
|
RMB |
|
RMB |
US$ |
Net loss |
(80,274,638 |
) |
|
(120,032,573 |
) |
(16,947,290 |
) |
Add: |
|
|
|
Share-based compensation expenses |
4,673,674 |
|
|
580,813 |
|
82,004 |
|
Non-GAAP adjusted net loss |
(75,600,964 |
) |
|
(119,451,760 |
) |
(16,865,286 |
) |
Nano Labs (NASDAQ:NA)
Historical Stock Chart
Von Nov 2024 bis Dez 2024
Nano Labs (NASDAQ:NA)
Historical Stock Chart
Von Dez 2023 bis Dez 2024